Filing Details
- Accession Number:
- 0001231977-10-000076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-23 16:17:01
- Reporting Period:
- 2010-11-19
- Filing Date:
- 2010-11-23
- Accepted Time:
- 2010-11-23 16:17:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337845 | Vikas Sinha | C/O Alexion Pharmacueticals, Inc. 352 Knotter Drive Cheshire CT 06410 | Svp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Acquisiton | 2010-11-19 | 20,000 | $13.79 | 93,281 | No | 4 | M | Direct | |
Common Stock, Par Value $.0001 Per Share | Disposition | 2010-11-19 | 20,000 | $75.00 | 73,281 | No | 4 | S | Direct | |
Common Stock, Par Value $.0001 Per Share | Acquisiton | 2010-11-22 | 4,000 | $16.35 | 77,281 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Option to Purchase Common Stock | Disposition | 2010-11-19 | 20,000 | $0.00 | 20,000 | $13.79 |
Common Stock, Par Value $.0001 Per Share | Option to Purchase Common Stock | Disposition | 2010-11-22 | 4,000 | $0.00 | 4,000 | $16.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
40,000 | 2005-12-21 | 2015-09-21 | No | 4 | S | Direct |
0 | 2006-09-07 | 2016-06-07 | No | 4 | S | Direct |
Footnotes
- The transaction reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.